Jang G - Search Results

1

Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity.

Kim KP, Jang G, Hong YS, Lim HS, Bae KS, Kim HS, Lee SS, Shin JG, Lee JL, Ryu MH, Chang HM, Kang YK, Kim TW. Kim KP, et al. Among authors: jang g. Br J Cancer. 2011 Feb 15;104(4):605-12. doi: 10.1038/bjc.2011.17. Br J Cancer. 2011. PMID: 21326246 Free PMC article. Clinical Trial.

2

Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer.

Park I, Lee JL, Ryu MH, Chang HM, Kim TW, Sym SJ, Lee SS, Jang G, Yoo C, Bae KS, Kang YK. Park I, et al. Among authors: jang g. Cancer Chemother Pharmacol. 2010 Feb;65(3):473-80. doi: 10.1007/s00280-009-1052-3. Epub 2009 Jun 24. Cancer Chemother Pharmacol. 2010. PMID: 19551382 Clinical Trial.

3

Dose escalation of imatinib after failure of standard dose in Korean patients with metastatic or unresectable gastrointestinal stromal tumor.

Park I, Ryu MH, Sym SJ, Lee SS, Jang G, Kim TW, Chang HM, Lee JL, Lee H, Kang YK. Park I, et al. Among authors: jang g. Jpn J Clin Oncol. 2009 Feb;39(2):105-10. doi: 10.1093/jjco/hyn134. Epub 2008 Dec 3. Jpn J Clin Oncol. 2009. PMID: 19052040

4

Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.

Jo JC, Kang BW, Sym SJ, Lee SS, Jang G, Kim S, Lee DH, Kim SW, Lee JS, Suh C. Jo JC, et al. Among authors: jang g. Invest New Drugs. 2011 Feb;29(1):175-81. doi: 10.1007/s10637-009-9343-4. Epub 2009 Oct 13. Invest New Drugs. 2011. PMID: 19823768

5

Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Kang BW, Kim WS, Kim C, Jang G, Lee SS, Choi YH, Lee DH, Kim SW, Kim S, Ryu JS, Huh J, Lee JS, Suh C. Kang BW, et al. Among authors: jang g. Invest New Drugs. 2010 Aug;28(4):516-22. doi: 10.1007/s10637-009-9283-z. Epub 2009 Jun 23. Invest New Drugs. 2010. PMID: 19547918 Clinical Trial.

6

Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea.

Jang G, Lee SS, Ahn JH, Jung KH, Lee H, Gong G, Kim HH, Ahn SD, Son BH, Ahn SH, Kim SB. Jang G, et al. Breast Cancer Res Treat. 2011 Jul;128(1):171-7. doi: 10.1007/s10549-011-1526-y. Epub 2011 Apr 26. Breast Cancer Res Treat. 2011. PMID: 21519835

7

Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.

Sohn BS, Park I, Kim EK, Yoon DH, Lee SS, Kang BW, Jang G, Choi YH, Kim C, Lee DH, Kim S, Huh J, Suh C. Sohn BS, et al. Among authors: jang g. Bone Marrow Transplant. 2009 Sep;44(5):287-93. doi: 10.1038/bmt.2009.29. Epub 2009 Feb 23. Bone Marrow Transplant. 2009. PMID: 19234508

8

BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity.

Jo JC, Kang BW, Jang G, Sym SJ, Lee SS, Koo JE, Kim JW, Kim S, Huh J, Suh C. Jo JC, et al. Among authors: jang g. Ann Hematol. 2008 Jan;87(1):43-8. doi: 10.1007/s00277-007-0360-0. Epub 2007 Aug 21. Ann Hematol. 2008. PMID: 17710401

9

A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancer.

Han B, Jung JY, Kim HS, Cho JW, Kim KC, Lim H, Kang HS, Ha HI, Kim MJ, Kim JH, Choi DR, Jang G, Kim JH, Song H, Zang DY. Han B, et al. Among authors: jang g. Cancer Chemother Pharmacol. 2016 Nov;78(5):949-958. doi: 10.1007/s00280-016-3147-y. Epub 2016 Sep 15. Cancer Chemother Pharmacol. 2016. PMID: 27628195 Clinical Trial.

10

A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer.

Kim HS, Lee GW, Kim JH, Kim HY, Kwon JH, Song HH, Kim HJ, Jung JY, Jang G, Choi DR, Park SM, Shin TR, Lee HS, Zang DY. Kim HS, et al. Among authors: jang g. Lung Cancer. 2010 Oct;70(1):71-6. doi: 10.1016/j.lungcan.2009.12.015. Epub 2010 Jan 21. Lung Cancer. 2010. PMID: 20096475 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,097 results

Search Page

Filters